GHTC delivers statement on global strategy on health, innovation, and IP at WHO Executive Board meeting
GHTC delivered a statement at the 148th session of the World Health Organization (WHO) Executive Board calling on WHO to address leading barriers to innovation of and access to essential health products. The statement, issued through the Global Health Council, urges WHO and member states to bolster regulatory capacity and harmonization, strengthen the Global Observatory on Health Research and Development, develop target product profiles for needed tools, and expand the Essential Diagnostics List as part of this effort.
Learn more